The Biomechanics and Multimodal Tissue Imaging (BMTI) Core is being proposed as a result of strategic restructuring of resources in the Center for Musculoskeletal Research (CMSR), in order to improve efficiency, accelerate the pace of research, and facilitate clinical translation of our NIH funded programs. As the research in the CMSR has moved in increasingly translational directions, including many animal models of orthopaedic injury and repair (e.g. arthritis, fracture healing, and allograft healing), there has been a compelling rationale for integrating histologic, tissue- and cell-based studies with longitudinal animal imaging and tissue biomechanical assessments, in pursuit of minimally-invasive outcome measures of healing and repair that can be translated from the bench to the bedside. The natural growth and success of the CMSR, the new initiative to increase collaborations between the CMSR and the Wellstone Muscular Dystrophy Cooperative Research Centers (MDCRC), the recent revamping up of our skeletal histopathology facilities, and the acquisition of state-of-the-art, sophisticated technologies through recent ARRA awards now necessitate the proposed organizational restructuring of our resources into separate Histology, Biochemistry and Molecular Imaging (HBMI) Core and Biomechanics and Mulfimodal Tissue Imaging (BMTI) Cores. This restructuring is sought to ensure the continued provision of efficient, high quality, histomorphometric, histologic, biomechanics, and in vivo imaging services to the investigators in the CMSR, such that the individual labs do not have to continually reproduce technical advances and modifications. Furthermore, the BMTI Core is designed to provide greater access of our large instrument fee for service Cores to unfunded physician scientists (UPS) and Research Assistant Professors (RAP) in our Core Center for Musculoskeletal Biology and Medicine (CCMBM).
The Aims of the BMTI Core are to provide high quality, consistent, efficient and cost-effective anatomic imaging and biomechanical testing in small animal models of musculoskeletal trauma and disease;to enhance and refine imaging modalities and novel image processing algorithms to derive translational correlates of functional healing;and to provide affordable access for RAP and UPS to Core resources, and utilize their unique research expertise to train other investigators, staff, and trainees in the CCMBM. The approach we have chosen is designed to improve service to our funded investigators at the highest levels of efficiency and quality, and facilitate the advancement of our RAP and UPS to independence, establishing them as future leaders that could potentially be recruited by the top academic programs in the country.

Public Health Relevance

A Biomechanics and Multimodal Tissue Imaging (BMTI) Core is being proposed to efficiently integrate histologic, tissue- and cell-based studies with longitudinal animal imaging and tissue biomechanical assessments, in pursuit of innovative minimally-invasive outcome measures of healing and repair that can be translated from the bench to the bedside.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR061307-04
Application #
8695292
Study Section
Special Emphasis Panel (ZAR1)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
4
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Rochester
Department
Type
DUNS #
City
Rochester
State
NY
Country
United States
Zip Code
14627
Schott, Eric M; Farnsworth, Christopher W; Grier, Alex et al. (2018) Targeting the gut microbiome to treat the osteoarthritis of obesity. JCI Insight 3:
Studentsova, Valentina; Mora, Keshia M; Glasner, Melissa F et al. (2018) Obesity/Type II Diabetes Promotes Function-limiting Changes in Murine Tendons that are not reversed by Restoring Normal Metabolic Function. Sci Rep 8:9218
Maynard, Robert D; Godfrey, Dana A; Medina-Gomez, Carolina et al. (2018) Characterization of expression and alternative splicing of the gene cadherin-like and PC esterase domain containing 1 (Cped1). Gene 674:127-133
Yukata, Kiminori; Xie, Chao; Li, Tian-Fang et al. (2018) Teriparatide (human PTH1-34) compensates for impaired fracture healing in COX-2 deficient mice. Bone 110:150-159
Ackerman, Jessica E; Best, Katherine T; O'Keefe, Regis J et al. (2017) Deletion of EP4 in S100a4-lineage cells reduces scar tissue formation during early but not later stages of tendon healing. Sci Rep 7:8658
Wang, Yuchen; Malcolm, Dominic W; Benoit, Danielle S W (2017) Controlled and sustained delivery of siRNA/NPs from hydrogels expedites bone fracture healing. Biomaterials 139:127-138
Elbarbary, Reyad A; Miyoshi, Keita; Myers, Jason R et al. (2017) Tudor-SN-mediated endonucleolytic decay of human cell microRNAs promotes G1/S phase transition. Science 356:859-862
Li, Xing; Sun, Wen; Li, Jinbo et al. (2017) Clomipramine causes osteoporosis by promoting osteoclastogenesis via E3 ligase Itch, which is prevented by Zoledronic acid. Sci Rep 7:41358
Trombetta, Ryan; Inzana, Jason A; Schwarz, Edward M et al. (2017) 3D Printing of Calcium Phosphate Ceramics for Bone Tissue Engineering and Drug Delivery. Ann Biomed Eng 45:23-44
Zhang, Longze; Wang, Tao; Chang, Martin et al. (2017) Teriparatide Treatment Improves Bone Defect Healing Via Anabolic Effects on New Bone Formation and Non-Anabolic Effects on Inhibition of Mast Cells in a Murine Cranial Window Model. J Bone Miner Res 32:1870-1883

Showing the most recent 10 out of 123 publications